EurofinsUS.com >> Eurofins US News >> Eurofins Food Safety Systems Announces SFSF Audits to NRA members

Eurofins Food Safety Systems Announces SFSF Audits to NRA members

Sidebar Image

Eurofins Food Safety Systems is proud to offer the American Feed Industry Association’s Safe Feed/Safe Food certification audits to members of the National Renderers Association.   This well-recognized assessment increases customer confidence, drives continuous improvement, and ensures regulatory compliance within the certified site.   

Renderers play a vital role in the national and international markets, and Eurofins is well positioned to serve this industry.   Eurofins has extensive experience with the SFSF program and thorough understanding of the rendering industry, both of which are vital to a successful audit.   Eurofins auditing team is experienced, calibrated, and able to accommodate the entire food and feed supply chain. 

“We look forward to working with NRA members on their certification and food safety goals.” said Eurofins Food Safety Systems Director, Gary Smith. “SFSF is a highly- recognized scheme that verifies a supplier’s food safety management systems meet the increasing stringent regulatory requirements and customer expectations.”

Eurofins Food Safety Systems is recognized for its efforts and capabilities as a food safety audit provider.   Participation in this audit program is another example of Eurofins’ food safety expertise and commitment to brand protection.  Eurofins offers support to NRA members and other SFSF certified sites through its training, consulting, auditing, and certification services and extensive testing capabilities, including Salmonella and EB.   Eurofins is a full service food safety provider to this industry.

For more information, please visit www.eurofinsus.com/food-safety


###

Eurofins Scientific is the world leader in food, environment and pharmaceutical products testing. It is also one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

With 20,000 staff in around 200 laboratories across 38 countries, Eurofins offers a portfolio of over 130,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.

Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.

As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.

The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).